lobbying_activities: 2998412

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2998412	7982292d-9389-4a55-9d2a-77ba060d07e7	Q2	CARDINAL POINT PARTNERS	308992	TONIX PHARMACEUTICALS, INC.	2023	second_quarter	DEF	Biodefense medical countermeasures research and development in the National Defense Authorization Act for FY2024 (no bill numbers).	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2023-07-03T14:02:01-04:00